No abstract available
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Angiotensin II / physiology
-
Angiotensin II / toxicity
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use
-
Animals
-
Cardiomegaly / chemically induced
-
Cardiomegaly / drug therapy
-
Cardiomegaly / physiopathology*
-
Cardiomegaly / prevention & control
-
Cytokines / metabolism
-
Drug Delivery Systems
-
ErbB Receptors / physiology
-
Fibroblasts / drug effects
-
Fibroblasts / physiology*
-
Heart Failure / drug therapy*
-
Heart Failure / etiology
-
Heart Failure / metabolism
-
Heart Failure / pathology
-
Heparin-binding EGF-like Growth Factor
-
Humans
-
Intercellular Signaling Peptides and Proteins / physiology
-
Isoproterenol / toxicity
-
Matrix Metalloproteinase Inhibitors
-
Matrix Metalloproteinases / physiology
-
Mice
-
Mice, Transgenic
-
Myocardium / metabolism
-
Myocardium / pathology*
-
Rats
-
Receptor, Angiotensin, Type 1 / physiology
-
Receptor, Serotonin, 5-HT2B / physiology*
-
Serotonin 5-HT2 Receptor Antagonists
-
Serotonin Antagonists / adverse effects
-
Serotonin Antagonists / therapeutic use
-
Signal Transduction / drug effects
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Cytokines
-
HBEGF protein, human
-
Hbegf protein, mouse
-
Hbegf protein, rat
-
Heparin-binding EGF-like Growth Factor
-
Intercellular Signaling Peptides and Proteins
-
Matrix Metalloproteinase Inhibitors
-
Receptor, Angiotensin, Type 1
-
Receptor, Serotonin, 5-HT2B
-
Serotonin 5-HT2 Receptor Antagonists
-
Serotonin Antagonists
-
Angiotensin II
-
ErbB Receptors
-
Matrix Metalloproteinases
-
Isoproterenol